FSTX Annual SG&A
$23.13 M
+$3.62 M+18.54%
31 December 2021
Summary:
As of February 5, 2025, FSTX annual selling, general & administrative expenses is $23.13 million, with the most recent change of +$3.62 million (+18.54%) on December 31, 2021. During the last 3 years, it has risen by +$7.85 million (+51.38%).FSTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FSTX Quarterly SG&A
$5.16 M
-$2.30 M-30.79%
30 September 2022
Summary:
As of February 5, 2025, FSTX quarterly selling, general & administrative expenses is $5.16 million, with the most recent change of -$2.30 million (-30.79%) on September 30, 2022. Over the past year, it has dropped by -$78.00 thousand (-1.49%).FSTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FSTX TTM SG&A
-$406.46 M
-$44.75 M-12.37%
30 September 2022
Summary:
As of February 5, 2025, FSTX TTM selling, general & administrative expenses is -$406.46 million, with the most recent change of -$44.75 million (-12.37%) on September 30, 2022. Over the past year, it has dropped by -$430.34 million (-1802.31%).FSTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FSTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.5% | -1.5% | -1802.3% |
| 3 y3 years | +51.4% | +61.8% | -10000.0% |
| 5 y5 years | +51.4% | +61.8% | -10000.0% |
FSTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -30.8% | -1669.4% |
F-star Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $5.16 M(-30.8%) | $23.28 M(-0.3%) |
| June 2022 | - | $7.46 M(+30.8%) | $23.36 M(+4.3%) |
| Mar 2022 | - | $5.70 M(+14.9%) | $22.40 M(-3.1%) |
| Dec 2021 | $23.13 M | $4.96 M(-5.3%) | $23.13 M(-3.1%) |
| Sept 2021 | - | $5.24 M(-19.4%) | $23.88 M(-7.8%) |
| June 2021 | - | $6.50 M(+1.1%) | $25.90 M(+14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $6.43 M(+12.6%) | $22.63 M(+16.7%) |
| Dec 2020 | $19.51 M(+27.7%) | $5.71 M(-21.4%) | $19.39 M(+41.7%) |
| Sept 2020 | - | $7.26 M(+124.4%) | $13.69 M(+113.0%) |
| June 2020 | - | $3.24 M(+1.5%) | $6.42 M(+101.5%) |
| Mar 2020 | - | $3.19 M | $3.19 M |
| Dec 2019 | $15.28 M | - | - |
FAQ
- What is F-star Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for F-star Therapeutics?
- What is F-star Therapeutics annual SG&A year-on-year change?
- What is F-star Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for F-star Therapeutics?
- What is F-star Therapeutics quarterly SG&A year-on-year change?
- What is F-star Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for F-star Therapeutics?
- What is F-star Therapeutics TTM SG&A year-on-year change?
What is F-star Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of FSTX is $23.13 M
What is the all time high annual SG&A for F-star Therapeutics?
F-star Therapeutics all-time high annual selling, general & administrative expenses is $23.13 M
What is F-star Therapeutics annual SG&A year-on-year change?
Over the past year, FSTX annual selling, general & administrative expenses has changed by +$3.62 M (+18.54%)
What is F-star Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of FSTX is $5.16 M
What is the all time high quarterly SG&A for F-star Therapeutics?
F-star Therapeutics all-time high quarterly selling, general & administrative expenses is $7.46 M
What is F-star Therapeutics quarterly SG&A year-on-year change?
Over the past year, FSTX quarterly selling, general & administrative expenses has changed by -$78.00 K (-1.49%)
What is F-star Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of FSTX is -$406.46 M
What is the all time high TTM SG&A for F-star Therapeutics?
F-star Therapeutics all-time high TTM selling, general & administrative expenses is $25.90 M
What is F-star Therapeutics TTM SG&A year-on-year change?
Over the past year, FSTX TTM selling, general & administrative expenses has changed by -$430.34 M (-1802.31%)